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OBJECTIVE — Although cumulative evidence suggests that increased oxidative stress may
lead to insulin resistance in vivo or in vitro, community-based studies are scarce. This study
examined the longitudinal relationships of oxidative stress biomarkers with the development of
insulin resistance and whether these relationships were independent of obesity in nondiabetic
young adults.
RESEARCH DESIGN AND METHODS — Biomarkers of oxidative stress (F2-
isoprostanes [F2Isop] and oxidized LDL [oxLDL]), insulin resistance (the homeostasis model
assessment of insulin resistance [HOMA-IR]), and various fatness measures (BMI, waist circum-
ference, and estimated percent fat) were obtained in a population-based observational study
(Coronary Artery Risk Development in Young Adults) and its ancillary study (Young Adult
Longitudinal Trends in Antioxidants) during 2000–2006.
RESULTS — ThereweresubstantialincreasesinestimatedmeanHOMA-IRovertime.OxLDL
and F2Isop showed little association with each other. Mean evolving HOMA-IR increased with
increasing levels of oxidative stress markers (P  0.001 for oxLDL and P  0.06 for F2Isop),
measured in 2000–2001. After additional adjustment for adiposity, a positive association be-
tween oxLDL and HOMA-IR was strongly evident, whereas the association between F2Isop and
HOMA-IR was not.
CONCLUSIONS — We observed positive associations between each of two oxidative stress
markers and insulin resistance. The association with oxidized LDL was independent of obesity,
but that with F2Isop was not.
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C
linical type 2 diabetes is considered
to be preceded by a long period of
insulin resistance, during which
blood glucose is maintained at near-
normal levels by compensatory hyperin-
sulinemia (1). Convincing evidence has
established that the level of insulin resis-
tance is a pre-diabetic state that can pre-
dict incident type 2 diabetes relatively far
into the future (2).
Increased oxidative stress appears to
be a deleterious factor leading to insulin
resistance, -cell dysfunction, impaired
glucose tolerance, and, ultimately, type 2
diabetes (3,4). Obesity may play a role in
the relationship between systemic oxida-
tive stress and these conditions (5).
Chronic oxidative stress is particularly
dangerous for -cells because pancreatic
islets are among those tissues that have
the lowest levels of antioxidant enzyme
expression, and -cells have high oxida-
tive energy requirements (4). In addition,
there is considerable evidence that in-
creased free radicals impair glucose-
stimulated insulin secretion, decrease the
gene expression of key -cell genes, and
induce cell death (4,6). If -cell function-
ing is impaired, it results in an underpro-
ductionofinsulin,fastinghyperglycemia,
and, eventually, the development of type
2 diabetes (7).
However, most previous studies in-
vestigating this association have been in
vitro or in small in vivo studies (8,9), and
data presenting an association between
the degree of oxidative stress and the risk
of developing insulin resistance among
nondiabetic people in the community are
scarce (9). We explored the associations
betweenoxidativestressandinsulinresis-
tance to see whether elevated levels of ox-
idative stress markers increase the risk of
future insulin resistance, whether differ-
ent biomarkers of oxidative stress show
consistent results, and whether these as-
sociationscanbeexplainedbyobesityina
longitudinaldesigninapopulation-based
cohort. We elected to study F2-isopro-
stanes (F2Isop) (10) and oxidized LDL




we tested the reciprocal relationship to
see if elevated levels of HOMA-IR were
associated with an increase in the level
of one oxidative stress marker
longitudinally.
RESEARCH DESIGN AND
METHODS— Data from the Coro-
nary Artery Risk Development in Young
Adults (CARDIA) study and its ancillary
study, Young Adult Longitudinal Trends
in Antioxidants (YALTA), were used to
examine the association between biomar-
kers of oxidative stress and insulin resis-
tance. Brieﬂy, CARDIA is a longitudinal
study aiming to investigate lifestyle and
other factors that inﬂuence the evolution
of cardiovascular disease in young adults.
This study began in 1985 with a cohort of
5,115 healthy black and white men and
women, aged 18–30 years, who were
free-living individuals residing in four
U.S. cities (Birmingham, AL; Chicago, IL;
Minneapolis,MN;andOakland,CA).The
YALTA ancillary study analyzes blood
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endothelial dysfunction, and related con-
cepts and interprets those data in con-
junction with the other data that have
beencollectedbyCARDIA.Follow-upex-
aminations were conducted during
1987–1988 (year 2), 1990–1991 (year
5),1992–1993(year7),1995–1996(year
10), 2000–2001 (year 15), and 2005–
2006 (year 20). The percentages of the
surviving cohort who returned for these
examinationswere90,86,81,79,74,and
72%, respectively. In this analysis, we in-
cluded all participants with F2Isop or ox-
LDL measurements at year 15 and fasting
insulin/fasting glucose measurements at
year 20. Among them, we excluded those
who had been diagnosed with diabetes,
deﬁned as a fasting glucose 126 mg/dl
(7mmol/l)orwhowerereceivingantidia-
betes medication between years 0 and 20
in our analysis.
Self-reported demographic (age, sex,
race, and educational level) and behav-
ioral (smoking, alcohol consumption,
andphysicalactivity)informationwasob-
tained across CARDIA examination visits.
Educational status was quantiﬁed as the
reported number of years of schooling
completed. Self-reported alcohol bever-
ages were quantiﬁed as average milliliters
of alcohol consumed per day, and smok-
ing status was classiﬁed as never, former,
or current smoker. An interviewer-
administered questionnaire queried par-
ticipation spent in leisure, occupational,
andhouseholdphysicalactivitiesoverthe
course of a year, weighting frequency and
intensity in order to obtain a total activity
score.
Anthropometry
The participants wore light clothes with-
out shoes during anthropometry. Body
weight was recorded to the nearest 0.2
pound. Body height was recorded to the
nearest0.5cm,andBMIwascalculatedas
weightinkilogramsdividedbythesquare
of height in meters, using the average of




between the iliac crest and the lowest lat-
eral portion of the ribcage and anteriorly
midway between the xyphoid process of
the sternum and the umbilicus, keeping
thetape(vinylanthropometriccentimeter
tape) horizontal.
Since the adiposity measurements,
total fat mass, and percent fat were ob-
tainedonlyfromasubsample(n1,072)
of the study participants, race- and sex-
speciﬁc predictive equations for percent
body fatness (%FAT) were computed us-
ingtheyear10dual-energyX-rayabsorp-
tiometry (DXA) examination (14); these
estimates enabled study of total body fat-
nessofeachparticipant.Year10DXAwas
obtained only from a subsample (n 
1,072), in Birmingham and Oakland, of
the study participants using the QDR
2000 (Hologic, Bedford, MA) with soft-
ware version 11.1. These race-/sex-
speciﬁc predictive equations included
age,BMI,waistcircumference(referredto




black men: %FAT  55.5371 to
0.0578  age  0.1585  BMI 
1.1741  WC  0.00365  WC
2; for
black women: %FAT  52.0734 
0.0901  age  1.9772  BMI 
0.9664  WC  0.015  BMI
2 
0.0051  WC
2; for white men: %FAT 
82.6174  0.1015  age  0.5448 
BMI  1.5883  WC  0.0065  WC
2;
and for white women: %FAT 
75.2741  0.1698  age  1.2678 
BMI1.7154WC0.00972WC
2.
These equations had higher correlation
coefﬁcients and smaller mean square er-
rors and predictive errors compared with
the widely used general predictive equa-
tions for body composition, such as the
Durnin and Womersley equations (15).
The correlations of observed year
10%FATwithpredictedvalueswereR
2
0.66 for black men, 0.76 for black
women, 0.60 for white men, 0.74 for
white women, and 0.82 for sex and race
combined, compared with R
2  0.75
for the Durnin and Womersley equations
that relied solely on skinfolds. These for-
mulae closely predicted DXA measured
fat and lean mass at year 20.
Blood components
Before drawing blood, all of the partici-
pants were asked to fast for 12 h and to
abstain from smoking for 2 h before their
examinations. After venous blood sam-
plesweredrawn,plasmawasseparatedby
centrifugation, transferred into airtight
vials, stored at 70°C, and shipped on
dry ice.
Fasting glucose and insulin were
measured at years 0, 7, 10, 15, and 20.
Glucose was measured in stored blood
samples using the hexokinase ultraviolet
method on a Cobas Mira Plus chemistry
analyzer. The insulin measurements were
performed by using a radioimmunoassay
with an overnight, equilibrium-incubation
format.BasedonreassaysofglucoseinDe-
cember 2007 in 200 samples stored
since year 7 and 100 samples stored since
year 15, glucose and insulin were recali-
brated to harmonize them with the previ-
ous measurements. Recalibrated glucose
valueswere6.980.94year7glucose
concentration, 7.15  0.96  year 10
glucose concentration, 6.99  1.01 
year 15 glucose concentration, and 4.06
 0.97  year 20 glucose concentration.
Recalibratedinsulinwas0.360.93
year 20 insulin concentration.
The biomarkers of oxidative stress
were obtained at year 15 and/or year 20.
F2Isop was measured at years 15 and 20
with gas chromatography–mass spec-
trometry. OxLDL concentrations were
measured by the Mercodia oxidized LDL
ELISA (Mercodia, Uppsala, Sweden) in
year 15 samples that had been stored at
70°C for several years. The antibody
(mAb-4E6) is directed against a confor-
mational epitope in the apolipoprotein
B-100moietyofLDL,asaconsequenceof
substitution of 60 lysine residues of
apolipoprotein B-100 with aldehydes,
and these substituting aldehydes can be
produced by peroxidation of lipids of
LDL, leading to the generation of oxLDL.
This method was compared with another
assay, developed by Holvoet et al. (11),
and showed the similar analytical perfor-
mance and clinical applicability (11).
Plasma levels of ascorbic acid were
measured using high-performance liquid
chromatography (HPLC) at year 15. Lev-
els of carotenoids (including lycopene,
-carotene,-carotene,-cryptoxanthin,
and zeaxanthin plus lutein) and toco-
pherols (-tocopherol and 	-tocopherol)
were obtained by HPLC at year 15. A com-
mon protocol and quality-control proce-
dures were used for all examinations.
Statistical analysis
BMI and waist circumference were set to
missing at each examination at which a
woman was pregnant. We investigated
patternsofrepeatedmeasurementsforin-
dividuals with large within-person SDs
fromyear0toyear20byvisualinspection
of the raw data to detect if there were any
substantial departures (e.g., outliers)
from patterns. Six outliers of waist cir-
cumference at year 15, one outlier of BMI
atyear20,oneoutlierofF2Isopatyear15,
and one outlier of HOMA-IR at year 7
were replaced with missing values. Insu-
lin resistance was assessed by HOMA-IR,
whichwascalculatedasfastingplasmain-
sulin (mU/l)  fasting plasma glucose
Park and Associates
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oxLDL, and circulating antioxidant
(ascorbic acid, lycopene, -carotene,
-carotene, -cryptoxanthin, zeaxanthin
plus lutein, -tocopherol, and 	-tocoph-
erol)estimateswerelogarithmicallytrans-
formed, since their distributions were
skewed to the right. The subjects were
classiﬁed into quartiles, based on their
levels of oxidative stress markers. Partial
correlation coefﬁcients between body fat
measurements/antioxidants and oxida-
tivestressmarkerswerecalculatedbysex,
adjusting for age and race.
Multivariablegeneralizedlinearmod-
els were used to test associations of oxi-
dative stress markers with evolving
HOMA-IR, using as dependent variable
HOMA-IR at year 20 and adjusting for
demographic and lifestyle factors (e.g.,
age, sex, race, study center, smoking sta-
tus, physical activity, alcohol consump-
tion, and education) and the previous
measure of HOMA-IR at year 15. In addi-
tion,themodelswereadjustedforadipos-
ity measurements (e.g., BMI, waist
circumference, and equation-driven esti-
mates of percent fat) to examine if the as-
sociation between oxidative stress and
insulin resistance was independent of
obesity. All analyses were conducted us-
ing SAS version 9.1.
RESULTS— The mean age of the par-
ticipants during 2000–2001 (year 15)
was 40 years, and 45% were men among
2,774 nondiabetic study participants.
Participants who had higher levels of
F2Isop were more likely to be women
(P  0.001) (Table 1). In contrast,
women had lower levels of oxLDL (P 
0.001). Education showed an inverse as-
sociation with both markers (P  0.001).
An increased level of F2Isop was posi-
tively associated with smoking (P 
0.001), whereas oxLDL was not associ-
ated with this factor. Physical activity was
inversely associated with both markers,
though the gradient was stronger over
F2Isop than over oxLDL.
Body fat measurements showed
strong positive associations with both
markers (P  0.01), as shown in Table 1.
F2Isop showed much stronger correla-
tions with adiposity markers in women
than in men (Table 2). Correlations be-
tweenF2Isopandbodyfatmeasurements,
including BMI, waist circumference, and
estimated body percent fat, were 0.40–
0.43 in women, whereas these correla-
tions were only 0.15–0.16 in men, after
adjustment for race and age. OxLDL did
not show a sex difference in the correla-
tionswithbodyfatmeasurements.F2Isop
wasnegativelycorrelatedwithsumofﬁve
serum carotenoids, ascorbic acid, and
-tocopherol but positively correlated
with serum 	-tocopherol. In contrast, the
correlations between oxLDL and antioxi-
dants were minimal. Interestingly, the
twooxidativestressmarkers,Isopandox-
LDL, were minimally correlated in our
sample (r  0.09, P  0.0007, in women
and r  0.003, P  0.9, in men).
Table 3 includes adjusted estimates
for year 20 HOMA-IR, according to the
quartiles of year 15 F2Isop and oxLDL.
We observed a signiﬁcant increase in the
estimates of evolving HOMA-IR with in-
creasing levels of oxLDL (P  0.001) and
a marginally signiﬁcant association with
F2Isop (P  0.06). After additional ad-
justment for the adiposity measurements,
oxLDL was still signiﬁcantly associated
with year 20 HOMA-IR, whereas the as-
sociation between F2Isop and HOMA-IR
became substantially attenuated. Further
adjustments for HDL cholesterol, LDL
cholesterol, and triglycerides did not af-
fect the magnitude and signiﬁcance of the
association between oxLDL and HOMA-
IR. Adiposity measurements remained
signiﬁcant, predicting HOMA-IR in the
models adjusted for either marker of oxi-
dative stress (P  0.0001).
In our analysis, we did not adjust for
medication use (e.g., lipid- or blood pres-
sure–loweringmedications)becausesuch
use could mediate or be directly corre-
lated with mediators in the causal path-
way for associations of oxidative stress on
insulin resistance. Omission of those tak-
ing these medications did not materially
change our study results (data not
shown). There were no signiﬁcant inter-
actions between oxidative stress markers
and other covariates, including sex, race,
smoking, adiposity measurements, and
physical activity. For example, although
the association between F2Isop and
HOMA-IRwaspositiveinwhitesandneg-
ative in blacks, race-speciﬁc coefﬁcients
were small and P values for interactions
were not signiﬁcant.
Increase in F2Isop was not predicted
by HOMA-IR in longitudinal analysis,
controlling for body fat measurements
(BMI, waist circumference, or estimated
body percent fat), age, sex, race, study
center, smoking status, physical activity,
alcohol consumption, education, and
F2Isop, all of which were measured in the
same year as the independent variable
(BMI-adjusted regression coefﬁcient 
0.004, P  0.9; waist circumference–
adjusted regression coefﬁcient 
0.009, P  0.7; body fat percent–
adjusted regression coefﬁcient 
0.008, P  0.7).
CONCLUSIONS — We observed
positive associations between oxidative
stress markers and insulin resistance in a
nondiabetic adult population. OxLDL
was positively associated with insulin re-
sistance,evenafteraccountingforvarious
adipositymeasurements,aﬁndingakinto
a recent report (12) in these data that ox-
LDL predicted incident metabolic syn-
drome. Although the association between
F2Isop and insulin resistance was also
positive, it was explained by additional
adjustment for adiposity measurements.
The levels of year 20 HOMA-IR predicted
by each oxidative stress marker were not
signiﬁcantly different by sex. Recently,
Meigs et al. (9) showed in a cross-
sectional design that the association be-
tween HOMA-IR and oxidative stress,
measured by urinary isoprostanes (8-epi-
PGF 2 /creatinine), was signiﬁcant, in-
dependent of BMI, but association
between insulin resistance prevalence
andoxidativestresswasattenuatedbyad-
ditional adjustment for BMI (P  0.06) in
individuals without type 2 diabetes in the
Framingham Offspring Cohort Study (9).
Our study substantially extends what is
known about the impact of oxidative
stress on insulin resistance in people
without diabetes. In our longitudinal
analysis, the results show that plasma
F2Isop was marginally related with ele-
vated levels of HOMA-IR, but a substan-
tial part of this association was explained
by anthropometric measurements (BMI
and waist circumference). Furthermore,
we examined this association by using an
alternate marker, oxLDL, that showed a
stronger association with insulin resis-
tance, independent of body fatness, com-
pared with F2Isop.
Oxidative stress results from an im-
balanced condition in which the genera-
tion of free radicals is greater than the
capacityoftheantioxidantdefensesystem
to detoxify them (17). When oxidative
stress is chronic, it is thought to result in
damage to DNA, lipids, proteins, and
othermolecules,whichmaycontributeto
the development and progression of
chronic disease, including cardiovascular
diseaseandcancer(13,18).Recently,var-
ious indirect markers of oxidative stress
havebeenusedinepidemiologicalstudies
to measure oxidation damage due to fea-
Oxidative stress and insulin resistance
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measures of free radicals and reactive ox-
ygen species, which include electron res-
onance or spin trapping, capturing free
radical reactions in real time (19). Among
them, oxLDL and F2Isop have been
known as robust reﬂectors of oxidative
stress in humans and have been widely
used in biology, medicine, and epidemi-
ological research (20,21). Each marker
may capture different stages of the oxida-
tive process or reﬂect different patho-
physiological pathways (22). The
apparent compartmentalization of oxida-
tive stress is illustrated in the differing as-
sociationsofF2Isop,oxLDL,anddifferent
carotenoids with each other and with
HOMA-IR. There was little correlation
between the two measures of oxidative
stress, though F2Isop was well correlated
with the sum of serum carotenoids and
other serum antioxidant vitamins (e.g.,
ascorbic acid and -tocopherol), lower
values of which in part indicate reduced
carotenoid intake and in part oxidative
stress. In contrast, correlations between
oxLDL and these antioxidant nutrients
were substantially weaker. In longitudi-
nal analysis using CARDIA/YALTA,
Hozawa et al. (23) reported that serum
carotenoid concentrations were inversely
associated with incident diabetes and
HOMA-IR in nonsmokers, concluding
that oxidative stress may be involved in
the development of type 2 diabetes in
nonsmokers. It has been reported that se-
rum carotenoids were inversely associ-
ated with F2Isop in the same data (24).
Our study shows that a substantial
portion of the association between F2Isop
and HOMA-IR was explained by body fat
measurements, and F2Isop was strongly
correlated with adiposity markers, espe-
cially in women. In a previous report us-
ing CARDIA/YALTA, Gross et al. (10)
reported that the level of plasma F2Isop
was higher in women, especially for those
with a BMI 25 kg/m
2, than men. Since
F2Isop is a product of lipid peroxidation,
it is closely related to adipose tissue mass,
especially for women. In contrast, corre-
lations between oxLDL and body fat mea-
surements did not differ by sex.
Furthermore,oxLDLwasastrongprecur-
sor of the risk of insulin resistance, inde-
pendent of obesity. Therefore, we suggest
that each oxidative stress marker may
capture a different oxidative stress path-
way and that their interaction with adi-
posity differs between men and women.
Nevertheless, in our study the estimated
levels of evolving HOMA-IR with increas-
ing levels of the oxidative stress markers
did not differ signiﬁcantly by sex.
Ourstudyhasseveralstrengths.Stud-
ies examining the longitudinal associa-
tions between oxidative stress and insulin
resistance are rare, especially with plasma
oxidative stress markers in healthy young
people in large, community-based stud-
ies, while most previous epidemiological
studies have used urinary markers. Also,
CARDIA has maintained a high participa-
tion rate and high-quality data collection
through rigorous quality-control proce-
dures throughout the study. Furthermore,
we could test prediction in the reverse di-
rection and added to the speciﬁcity of our
ﬁnding by showing that HOMA-IR did not
predictfutureoxidativestress,measuredby
F2Isop, although we only measured oxLDL
once and so were not able to measure the
reverse direction with it.
Amongpotentiallimitations,ﬁrst,ox-
idative stress is a highly complex phe-
nomenon and our measures may not be
sufﬁciently detailed to fully understand
the role of oxidative stress and adipose
tissue in development of insulin resis-
tance. Second, the study was conducted
only among black and white individuals,
with no representation of Hispanic,
Asian, or other individuals. As a result,
the conclusions from this study may not
be applicable to all populations. Finally,
Table 2—Sex-speciﬁc partial correlation coefﬁcients of observed body fat components, estimated percent body fat, and antioxidant markers at
year 15 with F2Isop and oxLDL
Adiposity and oxidative stress
markers
F2Isop oxLDL
n Women n Men n Women n Men
BMI (kg/m
2)* 1,509 0.43 1,260 0.15 1,418 0.25 1,184 0.23
Waist circumference (cm)* 1,506 0.40 1,259 0.16 1,416 0.31 1,183 0.26
Estimated body fat (%)‡ 1,506 0.41 1,258 0.16 1,416 0.28 1,182 0.26
Sum of ﬁve carotenoids (/dl)*§ 1,438 0.40 1,196 0.27 1,382 0.02† 1,139 0.06†
Ascorbic acids (g/dl)* 1,255 0.22 1,067 0.24 1,206 0.05† 1,017 0.004†
-Tocopherol (g/dl)*§ 1,438 0.29 1,196 0.30 1,382 0.02† 1,139 0.009†
	-Tocopherol (g/dl)*§ 1,438 0.27 1,196 0.23 1,382 0.03† 1,139 0.03†
F2Isop (g/dl)* 1,513 1 1,261 1 1,419 0.09 1,185 0.003†
*All models were adjusted for age and race. †P  0.05. ‡Based on race-/sex-speciﬁc prediction from BMI, waist circumference, and age; see RESEARCH DESIGN AND
METHODS. §Additional adjustment for year 15 HDL cholesterol, LDL cholesterol, and triglycerides (25). Sum of ﬁve carotenoids: -carotene, -carotene, -cryp-
toxanthin, lutein/zeaxanthin, and lycopene.
Table 3—Relationship between year 15 oxidative stress markers and year 20 HOMA-IR
F2Isop oxLDL
-Coefﬁcient 
 SE P -Coefﬁcient 
 SE P
Model 1* 0.0244 
 0.0158 0.1 0.0727 
 0.0208 0.0005
Model 2† 0.0294 





 0.0165 0.2 0.0598 
 0.0206 0.004
Waist circumference (cm)‡ 0.0237 
 0.0161 0.1 0.0432 
 0.0206 0.04
Estimated body fat (%)‡ 0.0217 
 0.0163 0.2 0.0501 
 0.0206 0.02
-Coefﬁcient is a change in HOMA-IR 
ln (mU   l
1   mmol
1   l
1) per one-unit increment of independent
variables 
ln(F2Isop) (ng/l) or ln(oxLDL) (units/l). *Model 1: adjusting for age, sex, race, study center, and
year 15 HOMA-IR. †Model 2: model 1 plus year 15 smoking status, physical activity, alcohol consumption,
and education. ‡Model 3: model 2 plus year 15 body fat measurements (BMI, waist circumference, or
estimated percent body fat; adding each variable separately).
Oxidative stress and insulin resistance
1306 DIABETES CARE, VOLUME 32, NUMBER 7, JULY 2009there could be residual confounding due
to this study’s observational nature.
Insummary,ourresultsshowthatin-
creased oxidative stress is associated with
evolution of insulin resistance. The inde-
pendent association of oxLDL with insu-
linresistancesupportsthehypothesisthat
oxidativestressleadstoinsulinresistance,
independent of obesity. F2Isop is closely
correlated with adiposity, especially for
women, and it is possible that F2Isop is
intermediate in a pathway that links insulin
resistance with total body fat. Further re-
searchisneededtoelucidatetheunderlying
etiological relationships between adiposity
and oxidative stress in the genesis and pro-
gression of insulin resistance by various bi-
omarkers of oxidative stress and body fat
measurements in diverse populations.
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